WEDBUSH SECURITIES INC - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$50,000
-34.2%
94,046
-4.3%
0.01%
-22.2%
Q4 2017$76,000
+4.1%
98,255
+96.5%
0.01%0.0%
Q3 2017$73,00050,0000.01%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2017
NameSharesValueWeighting ↓
IMS Capital Management 246,966$1,778,0002.19%
WELCH & FORBES LLC 902,286$6,496,0000.21%
Alambic Investment Management, L.P. 25,100$181,0000.11%
EMERSON INVESTMENT MANAGEMENT, LLC 74,175$534,0000.10%
Hayek Kallen Investment Management 10,965$79,0000.06%
Yellowstone Partners, LLC 10,045$72,0000.03%
Ausdal Financial Partners, Inc. 7,750$56,0000.03%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 29,647$213,0000.03%
GROUP ONE TRADING, L.P. 61,856$445,0000.01%
Cambridge Investment Research Advisors, Inc. 10,500$76,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders